Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
+0.0150 (17.65%)
Sep 18, 2025, 11:43 AM EDT
17.65%
Market Cap1.39M
Revenue (ttm)n/a
Net Income (ttm)-360.40K
Shares Out13.86M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,000
Average Volume8,191
Open0.1000
Previous Close0.0850
Day's Range0.1000 - 0.1000
52-Week Range0.0850 - 0.3800
Beta1.48
RSI55.09
Earnings DateOct 24, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.